Blog

POLARIS has been named a finalist for the Langland Award for Excellence in Healthcare Partnership

Logo of Servier Pharmaceuticals from LinkedIn

Jul 4, 2024, 16:15

POLARIS has been named a finalist for the Langland Award for Excellence in Healthcare Partnership

Servier Pharmaceuticals shared on LinkedIn:

“We are excited to announce that POLARIS, our innovative project to enhance communication for acute lymphoblastic leukaemia (ALL) treatment, has been named a finalist for the Langland Award for Excellence in Healthcare Partnership!

POLARIS was a collaborative development between Servier, SIOP Europe, CCI Europe, Syneos Health France and the Velella Group, that provides clear, accessible treatment roadmaps and personalized web-based support, helping families track treatments in real-time and in their native languages.

Thank you to our partners and to the Communique Awards for this recognition! We remain committed to empowering families and improving the ALL treatment journey.”

Read further.
Source: Servier Pharmaceuticals/LinkedIn

Acute Lymphoblastic leukaemia (ALL) cancer CCI Europe Communique Awards Langland Award for Excellence in Healthcare Partnership OncoDaily Oncology POLARIS Servier Pharmaceuticals SIOP Europe Syneos Health France Velella Group

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage